Related Experiment Video
Updated: May 23, 2026

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Vitamin D and atopy and asthma phenotypes in children
1Telethon Institute for Child Health Research, Centre for Child Health Research, University of Western Australia, Perth, Western Australia, Australia. elysiah@ichr.uwa.edu.au
Insights
Low vitamin D levels in children are linked to increased risk of atopy and asthma. Ensuring adequate vitamin D during pregnancy and childhood may help prevent these conditions.
Area of Science:
- Pediatric Allergy and Immunology
- Respiratory Medicine
- Nutritional Science
Background:
- Atopy and asthma are significant childhood health concerns.
- The role of vitamin D in immune system regulation is increasingly recognized.
- Existing research suggests potential links between vitamin D deficiency and allergic diseases.
Purpose of the Study:
- To review current research on the association between vitamin D deficiency and childhood atopy and asthma.
- To explore epidemiological and mechanistic evidence supporting this link.
- To identify knowledge gaps and future research directions.
Main Methods:
- Review of recent epidemiological studies correlating vitamin D status with atopy and asthma in children.
- Analysis of mechanistic studies investigating vitamin D's role in relevant biological processes.
- Focus on determinants of childhood asthma phenotypes and vitamin D's impact.
Main Results:
- Vitamin D levels show an inverse association with corticosteroid use, airflow limitation, and exacerbations in asthmatic children.
- Low vitamin D is linked to atopy and asthma in children and adolescents, particularly in boys.
- Vitamin D levels at age 6 predicted atopy and asthma outcomes at age 14.
- Mechanistic studies show vitamin D deficiency in pregnancy leads to reduced lung function in offspring.
Conclusions:
- Current evidence suggests that maintaining adequate vitamin D levels during pregnancy and childhood may reduce the incidence of atopy and asthma.
- Further research is needed to determine optimal vitamin D levels, timing, and duration of intervention.
- Sex and individual variations in vitamin D requirements warrant further investigation.
Purpose Of Review:
To give an overview of the recent research into whether a lack of vitamin D contributes to the development of atopy and asthma in childhood.
Recent Findings:
I describe here the recent epidemiological studies relating vitamin D status to atopy and asthma in children, focusing on determinants of major asthma phenotypes in childhood. Recent findings include the observations that vitamin D levels are inversely associated with degree of corticosteroid use, worsening airflow limitation and increased exacerbations among asthmatics. Low vitamin D has been associated with atopy and asthma in children and adolescents in a community cohort, predominantly in boys, with vitamin D at age 6 predicting these outcomes at 14. I also detail the mechanistic studies examining relevant vitamin D-regulated processes; recent findings include the demonstration that offspring of mice with vitamin D deficiency in pregnancy show reduced lung volume and function.
Summary:
The current literature suggests that intervention to ensure adequate vitamin D levels during both pregnancy and childhood may reduce the development of atopy and asthma in children. However, important questions need to be answered regarding the levels of vitamin D required, which may vary between the sexes and between individuals, and the optimal timing and duration of such intervention.
Related Concept Videos
Asthma I: Introduction
Asthma-I: Introduction
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma III: Clinical Manifestations
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
